secwatch.observer — SEC 8-K summary
======================================

Issuer:     Estrella Immunopharma, Inc. (ESLA)
CIK:        0001844417
Form:       8-K
Filed at:   2026-06-30T21:29:37+00:00
Accession:  0001213900-26-073847
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Estrella Immunopharma stockholders ratify auditor at 2025/2026 annual meeting
-----------------------------------------------------------------------------

- Ratified Macias Gini & O'Connell LLP as independent auditor for fiscal year ending Dec 31, 2026.
- Votes: 30,351,203 for, 400 against, 5 abstain; no broker non-votes.
- Annual meeting held June 29, 2026; quorum of ~70.5% of outstanding shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1844417/000121390026073847/0001213900-26-073847-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1844417/000121390026073847/ea029661701-8k_estrella.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-073847

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer